Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)
- PMID: 38571815
- PMCID: PMC10988127
- DOI: 10.1016/j.ncrna.2024.01.002
Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)
Abstract
Polycystic ovary syndrome (PCOS) is the most common condition affecting women of reproductive age globally. PCOS continues to be the largest contributing factor to female infertility despite significant progress in our knowledge of the molecular underpinnings and treatment of the condition. The fact that PCOS is a very diverse condition makes it one of the key reasons why we haven't been able to overcome it. Non-coding RNAs (ncRNAs) are implicated in the development of PCOS, according to growing evidence. However, it is unclear how the complex regulatory relationships between the many ncRNA types contribute to the growth of this malignancy. Competing endogenous RNA (ceRNA), a recently identified mechanism in the RNA world, suggests regulatory interactions between various RNAs, including long non-coding RNAs (lncRNAs), microRNAs (miRNAs), transcribed pseudogenes, and circular RNAs (circRNAs). Recent studies on PCOS have shown that dysregulation of multiple ceRNA networks (ceRNETs) between these ncRNAs plays crucial roles in developing the defining characteristics of PCOS development. And it is believed that such a finding may open a new door for a deeper comprehension of PCOS's unexplored facets. In addition, it may be able to provide fresh biomarkers and effective therapy targets for PCOS. This review will go over the body of information that exists about the primary roles of ceRNETs before highlighting the developing involvement of several newly found ceRNETs in a number of PCOS characteristics.
Keywords: Circular RNAs; Competing endogenous RNA (ceRNA); Long noncoding RNA; MicroRNAs; Polycystic ovary syndrome; Regulatory networks.
© 2024 The Authors.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures
![Image 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10988127/bin/ga1.gif)
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10988127/bin/gr1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10988127/bin/gr2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10988127/bin/gr3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10988127/bin/gr4.gif)
Similar articles
-
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks.Infect Genet Evol. 2024 Aug;122:105613. doi: 10.1016/j.meegid.2024.105613. Epub 2024 Jun 4. Infect Genet Evol. 2024. PMID: 38844190 Review.
-
Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.Hum Reprod. 2022 Nov 24;37(12):2856-2866. doi: 10.1093/humrep/deac218. Hum Reprod. 2022. PMID: 36223608
-
Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.Life Sci. 2021 Jul 15;277:119488. doi: 10.1016/j.lfs.2021.119488. Epub 2021 Apr 19. Life Sci. 2021. PMID: 33862117 Review.
-
Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis.Reprod Biol Endocrinol. 2021 Jan 14;19(1):10. doi: 10.1186/s12958-020-00687-9. Reprod Biol Endocrinol. 2021. PMID: 33446212 Free PMC article.
-
Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.J Cell Physiol. 2019 Jul;234(7):10080-10100. doi: 10.1002/jcp.27941. Epub 2018 Dec 10. J Cell Physiol. 2019. PMID: 30537129 Review.
References
-
- Escobar-Morreale H.F., Defining P.C.O.S. A syndrome with an intrinsic heterogeneous nature. Polycystic Ovary Syndr. 2022:3–13. doi: 10.1016/B978-0-12-823045-9.00012-2. - DOI
Publication types
LinkOut - more resources
Full Text Sources